124.920USD+124.920盘后交易 07/31, 20:00 (美东)
关键数据
127.260今开
127.510最高
1.24M成交量
--市盈率 TTM
0.00市盈率动
--股息TTM
--换手率
124.330昨收
120.620最低
82.17M成交额
--市盈率静
--市净率
0.00%股息率 TTM
--ROA
148.83052周最高
1.17量比
--净利润
--总股本
--每股收益TTM
--Beta
--ROE
5.69052周最低
5.54%振幅
--毛利率
0.00总市值
-4.50回报/风险
3.12%风险率
Abivax SA新闻
即将为您带来更多新闻,敬请期待。。。
收益预测
Ionis Pharmaceuticals Inc
IONS
25
技术指标
Abivax SA简介
Abivax SA is a clinical stage biopharmaceutical company focusing on the discovery, development and commercialization of anti-viral compounds and therapeutic vaccines against severe and life threatening infectious diseases. ABIVAX utilizes RNA-protein interaction interference and cytotoxic TH1 cell amplification to generate therapies to help patients clear viruses like HIV, HBV and HPV. The Company's product pipeline comprises ABX 203, which is the therapeutic vaccine candidate obtained from the Centre for Genetic Engineering and Biotechnology, Cuba (CIGB) and is intended for patients with chronic hepatitis B disease; and ABX196, the adjuvant for therapeutic vaccines, among others.
公司代码ABVX
公司Abivax SA
CEOde Garidel (Marc)
网址https://www.abivax.com/
公司股东
常见问题
Abivax SA(ABVX)的当前股价是多少?
Abivax SA(ABVX)的当前股价是 124.81。
Abivax SA股票的52周最高点是148.83。
现在Abivax SA(ABVX)的股票是买入、持有还是卖出?
根据分析师评级,Abivax SA(ABVX)的总体评级为买入,目标价格为156.15。